AAA
ZURA icon

Affinity Asset Advisors’s Zura Bio ZURA Stock Holding History

Affinity Asset Advisors’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.3M Buy
2,564,303
+750,632
+41% +$4.53M 0.79% 35
2025
Q4 		$9.5M Buy
1,813,671
+539,320
+42% +$2.13M 0.54% 47
2025
Q3 		$5.52M Buy
1,274,351
+1,051,016
+471% +$1.89M 0.48% 48
2025
Q2 		$235K Hold
223,335
– – 0.03% 83
2025
Q1 		$288K Hold
223,335
– – 0.03% 89
2024
Q4 		$558K Hold
223,335
– – 0.07% 75
2024
Q3 		$907K Hold
223,335
– – 0.12% 74
2024
Q2 		$782K Sell
223,335
-226,674
-50% -$924K 0.09% 84
2024
Q1 		$1.16M Buy
+450,009
New +$1.59M 0.14% 81

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Affinity Asset Advisors's ZURA Position: Q1 2026 in Review

Affinity Asset Advisors increased its Zura Bio (ZURA) stake by 41% in Q1 2026, buying an estimated $4.53M and bringing the position to 2,564,303 shares worth $15.3M. The position accounts for 0.79% of the portfolio, ranked #35.

Affinity Asset Advisors first reported a position in ZURA in Q1 2024 and has held it in 9 quarters since. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • Affinity Asset Advisors held 2,564,303 shares of Zura Bio worth $15.3M as of Q1 2026.
  • Affinity Asset Advisors bought 750,632 Zura Bio shares in Q1 2026, an estimated $4.53M.
  • Zura Bio made up 0.79% of Affinity Asset Advisors's portfolio in Q1 2026, its #35 holding.
  • Affinity Asset Advisors first reported a position in Zura Bio in Q1 2024 and has held it in 9 quarters since.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Affinity Asset Advisors's 13F filing for Q1 2026, filed 14 May 2026.